Promising drug targets severe hunger and obesity in rare genetic disorder
NCT ID NCT06772597
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 24 times
Summary
This study tests a daily injection called setmelanotide in people aged 6 to 65 with Prader-Willi syndrome, a genetic condition causing severe obesity and constant hunger. The goal is to see if the drug is safe and helps reduce body weight and hunger over 52 weeks. Up to 18 participants will receive the drug, and researchers will track side effects and changes in BMI.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Florida
Gainesville, Florida, 32610-0296, United States
Conditions
Explore the condition pages connected to this study.